Tasigna hard capsules are indicated for the: treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase; treatment of chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) in adult patients resistant to or intolerant to at least one prior therapy including imatinib.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
